Nurosym vs Apollo Neuro: two devices with opposite credentials

Nurosym delivers a small electrical current to the auricular branch of the vagus nerve at the tragus. That is transcutaneous vagus nerve stimulation in the sense the research literature uses the term.

Apollo Neuro delivers patterned vibration to touch receptors in the skin of the wrist or ankle. No current, no nerve stimulated directly. The company’s framing is that particular rhythms shift you toward a calmer autonomic state.

Apollo is listed alongside vagus nerve devices everywhere, including in our own roundup, which is why this comparison exists at all. If you specifically want the thing the tVNS studies studied, only one of these two is it.

Count publications and Apollo wins. Ask what the publications are about and the picture changes shape.

Apollo returns 17 records on a PubMed search for the device. Four name it directly, in the American Journal of Medicine, the Journal of Rheumatology, JMIR mHealth and uHealth and the Journal of Psychiatric Research, covering wellbeing in medical students, fatigue in systemic sclerosis, sleep and anxiety during ketamine assisted therapy. Several are small. That is still more device specific published work than any electrical device in this category has.

Nurosym has fewer papers and they sit inside the field you are probably shopping in. A sham controlled randomized trial in postural tachycardia syndrome names the Parasym device in its full text methods, and a long COVID pilot names the Parasym system. The POTS trial ran 12 active against 14 sham, so it is small, and it is a real controlled trial of the actual hardware.

Two different currencies. If your question is which product has been studied more, Apollo. If your question is what does the vagus nerve stimulation research support and which device did it use, Nurosym. Our full read of that literature sets out how strong it is, including where it does not hold up.

Nurosym is the biggest time commitment in this category. Thirty to sixty minutes daily on a wired clip, no app, nothing to configure. It is closer to taking a medication than to using a gadget. Some people find that clarity easier and others cannot sustain it.

Apollo is the opposite. Put it on, pick a mode, forget about it. The cost of that is a six to ten hour battery, so it charges daily, and the fact that you are wearing something continuously.

Neither format is better in the abstract. What matters is which one survives contact with a bad week.

Nurosym is a single payment with no app and no subscription. The manufacturer says the battery lasts weeks; the earpiece electrode is the replaceable part and carries six months against two years on the device. In the US it is HSA and FSA eligible, which changes the effective price for some buyers.

Apollo is $448 for the wearable bundled with a SmartVibes AI membership and a sleep band. The modes run through the app, so the membership is part of the product rather than an optional extra.

The gap is $452 up front. Whether that reads as expensive depends entirely on which of the two credentials above you were shopping for.

Pick Nurosym if you want the device named in vagus nerve trial methods, you want CE medical device certification, you want no app and nothing further to pay, or you are dealing with something like POTS or long COVID where the published work sits.

Pick Apollo if continuous wear is the appeal, if scheduling anything is what has defeated you before, or if you own an Oura Ring and want the integration.

Consider the neck instead if you want electrical stimulation without an hour a day or a $900 outlay. Worn neck devices start at $259 with sessions from four minutes.